Author

AL Delson

Observed name: A. Delson

Institution: University of California, San Francisco

Observed institutions: Translational Genomics Research Institute, Mayo Clinic, Duke University, University of California, San Francisco, University of Alabama at Birmingham, Natera (United States), University of Pennsylvania

OpenAlex ID: A5080636347

Abstract PD2-01: Personalized serial circulating tumor DNA (ctDNA) analysis in high-risk early stage breast cancer patients to monitor and predict response to neoadjuvant therapy and outcome in the I-SPY 2 TRIAL

2019 · MJM Magbanua, L Brown-Swigart, et al. · Cancer Research · 9

Abstract PD6-07: Ctdna dynamics is most predictive of response in treatment-sensitive response-predictive subtypes of breast cancer: results from the I-SPY2 trial

2026 · M. Magbanua, D. Wolf, et al. · Clinical Cancer Research

Abstract P3-01-02: Detection of circulating tumor cells (CTC) in blood and disseminated tumor cells (DTC) in bone marrow at surgery identifies breast cancer patients (pts) with long-term risk of distant recurrence and breast cancer-specific death

2019 · MJM Magbanua, C Yau, et al. · Cancer Research

Works count: 3

Citation count: 9

H-index: 1

I10-index: